Rocket Pharmaceuticals logo
Rocket Pharmaceuticals RCKT
$ 11.39 0.35%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Rocket Pharmaceuticals Total Liabilities 2011-2024 | RCKT

Annual Total Liabilities Rocket Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
73.8 M 62.1 M 42.3 M 87.3 M 64.8 M 57.3 M 54 M 56.5 M 4.51 M 10.3 M 10.5 M 3.79 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
87.3 M 3.79 M 43.9 M

Quarterly Total Liabilities Rocket Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
63.9 M 61.8 M 57.9 M 73.8 M 57.7 M 58.8 M 55.9 M 62.1 M 50 M 44.2 M 42.5 M 42.3 M 44.6 M 45.7 M 96.5 M 87.3 M 87.3 M 87.3 M 87.3 M 64.8 M 64.8 M 64.8 M 64.8 M 57.3 M 57.3 M 57.3 M 57.3 M 4.63 M 4.63 M 4.63 M 4.63 M 56.5 M 56.5 M 56.5 M 56.5 M 4.51 M 4.51 M 4.51 M 4.51 M 10.3 M 10.3 M 10.3 M 10.3 M - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
96.5 M 4.51 M 46.5 M